A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.

EGFR-mutated lung cancer NSCLC actionable mutations in NSCLC early-stage NSCLC lung cancer targeted therapies

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Jun 2022
Historique:
received: 09 03 2022
revised: 09 06 2022
accepted: 09 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

The approval of osimertinib for adjuvant treatment of stage I-II-III

Identifiants

pubmed: 35740637
pii: cancers14122971
doi: 10.3390/cancers14122971
pmc: PMC9221477
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cancer Manag Res. 2018 Sep 10;10:3393-3404
pubmed: 30237741
Virchows Arch. 2018 Oct;473(4):489-503
pubmed: 30105577
Clin Cancer Res. 2021 Dec 15;27(24):6638-6643
pubmed: 34301748
J Hematol Oncol. 2021 Jul 8;14(1):108
pubmed: 34238332
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Lancet. 2021 Aug 7;398(10299):535-554
pubmed: 34273294
Transl Oncol. 2018 Dec;11(6):1364-1369
pubmed: 30196239
Ann Oncol. 2013 Apr;24(4):986-92
pubmed: 23161898
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
Front Oncol. 2020 Dec 10;10:610923
pubmed: 33363040
Anticancer Res. 2010 Nov;30(11):4695-9
pubmed: 21115926
N Engl J Med. 2021 Jun 24;384(25):2371-2381
pubmed: 34096690
J Clin Oncol. 2018 Aug 28;:JCO2018783118
pubmed: 30153097
J Thorac Oncol. 2021 May;16(5):764-773
pubmed: 33333327
Expert Rev Anticancer Ther. 2018 Jan;18(1):63-70
pubmed: 29168933
Arch Pathol Lab Med. 2013 Sep;137(9):1191-8
pubmed: 23991729
Cancers (Basel). 2021 Jul 20;13(14):
pubmed: 34298851
J Cell Biol. 2020 Jan 6;219(1):
pubmed: 31816057
J Clin Oncol. 2018 Sep 10;36(26):2702-2709
pubmed: 30059262
Lung Cancer. 2021 Apr;154:161-175
pubmed: 33690091
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
J Clin Oncol. 2017 Sep 1;35(25):2960-2974
pubmed: 28437162
Cancer Treat Rev. 2020 Apr;85:101994
pubmed: 32113081
N Engl J Med. 2020 Oct 29;383(18):1711-1723
pubmed: 32955177
Transl Lung Cancer Res. 2020 Aug;9(4):1343-1360
pubmed: 32953509
J Clin Oncol. 2020 Feb 10;38(5):488-495
pubmed: 31825714
Lancet Oncol. 2015 Apr;16(4):e165-72
pubmed: 25846096
Pathol Oncol Res. 2020 Jan;26(1):79-89
pubmed: 30225784
Ann Oncol. 2010 Oct;21 Suppl 7:vii196-8
pubmed: 20943614
J Cancer. 2019 Jun 9;10(15):3553-3559
pubmed: 31293660
Mol Clin Oncol. 2016 Dec;5(6):705-713
pubmed: 28101350

Auteurs

Irene Terrenato (I)

UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Cristiana Ercolani (C)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Anna Di Benedetto (A)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Enzo Gallo (E)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Elisa Melucci (E)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Beatrice Casini (B)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Francesca Rollo (F)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Aldo Palange (A)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Paolo Visca (P)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Edoardo Pescarmona (E)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Enrico Melis (E)

Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Filippo Gallina (F)

Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Andrea Sacconi (A)

UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Fabiana Letizia Cecere (FL)

Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Lorenza Landi (L)

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Federico Cappuzzo (F)

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Gennaro Ciliberto (G)

Scientific Direction, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Simonetta Buglioni (S)

Pathology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Classifications MeSH